Loading stock…

NewMarket Corporation (NEU) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

NewMarket Corporation

NEUMarket cap $8.52BPrice $926.3

Country🇺🇸United States

SectorMaterials

IndustryChemicals

NewMarket makes petroleum additives that keep engines and fuels running smoothly, through subsidiary Afton Chemical. It quietly dominates a niche market, supplying nearly every major oil company and automaker with the chemistry that lubricates modern transportation.

In Bastion Portfolios?

52W Return+21%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-0%3

Revenue Forecast

Rev CAGR (1y)-9%1

Rev CAGR (3y)-3%1

Rev CAGR (5y)-2%1

Earnings Forecast

EPS Growth Y+1-38%2

EPS Growth Y+20%4

EPS Growth Y+30%4

Quality

Margins

EBIT Margin22%8

Net Income Margin16%7

Free Cash Flow Margin17%7

Debt

Net Debt/EBITDA1.16

Efficiency

ROE25%9

ROA13%9

Earnings Stability77

GEAR+AVERAGE39

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)312

P/E Ratio (Forward 3y)311

P/BV4.63

EV Multiples

EV/EBITDA Fwd163

EV/EBIT Fwd243

Yield

Free Cash Flow Yield5.6%7

Dividend Yield1.3%4

Momentum

Short term

1 month return+5%9

3 month return+17%9

YTD return+36%9

Mid term

Price vs 52wHigh95%9

1 year return+10%6

Long term

3 year return+112%8

5 year return+193%9

Risk Shield

Price Risk

Beta0.76

Volatility34%6

Free Cash Flow

Free Cash Flow Margin17%7

Free Cash Flow Yield5.6%7

Quality

ROCE20%9

Earnings Stability77

Net Debt/EBITDA1.16

02Growth

Is it actually growing, and how fast?

NEUNewMarket

Revenue FY25$2.8B

GROWTH RATING↗

VERY WEAK3 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-0%3

Revenue, next 1Y-9%1

Revenue, next 3Y, CAGR-3%1

Revenue, next 5Y, CAGR-2%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-38%2

EPS growth, FY27E0%4

EPS growth, FY28E0%4

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 97% of companies worldwide.

Revenue held flat over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to shrink 3%/yr over the next 3 years, behind most of the market.1/10

Revenue held flat over the last 3 years and is set to keep shrinking around 3%/yr.

Over five years revenue is set to shrink 2%/yr, behind 90% of companies worldwide.1/10

Earnings are set to fall along with revenue (EPS about 0%/yr vs revenue -3%/yr).

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is still shrinking. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG91 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+5%9

3-month return+17%9

YTD return+36%9

MID & LONG-TERM▾SCORE

% of 52-week high95%9

1-year return+10%6

3-year return+112%8

5-year return+193%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +112% over three years and +193% over five, ahead of 80% of the market.

It's up 10% over the past year, now 5% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+5%), over three months (+17%) and so far this year (+36%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on NewMarket Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

NEUNewMarket

Revenue FY25$2.8B

GROWTH RATING↗

VERY WEAK3 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-0%3

Revenue, next 1Y-9%1

Revenue, next 3Y, CAGR-3%1

Revenue, next 5Y, CAGR-2%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-38%2

EPS growth, FY27E0%4

EPS growth, FY28E0%4

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 97% of companies worldwide.

Revenue held flat over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to shrink 3%/yr over the next 3 years, behind most of the market.1/10

Revenue held flat over the last 3 years and is set to keep shrinking around 3%/yr.

Over five years revenue is set to shrink 2%/yr, behind 90% of companies worldwide.1/10

Earnings are set to fall along with revenue (EPS about 0%/yr vs revenue -3%/yr).

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is still shrinking. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG91 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+5%9

3-month return+17%9

YTD return+36%9

MID & LONG-TERM▾SCORE

% of 52-week high95%9

1-year return+10%6

3-year return+112%8

5-year return+193%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +112% over three years and +193% over five, ahead of 80% of the market.

It's up 10% over the past year, now 5% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+5%), over three months (+17%) and so far this year (+36%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on NewMarket Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community